Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-05 · 44 (5) · 1098-1100
DOI: 10.1161/atvbaha.124.320817 ↗Kurz gefasst
Editorial in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-05. Verfasst von Nayere Taebnia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (N.T., V.M.L.). Hauptthemen laut MEDLINE: Hypothyroidism, Angiopoietin-like Proteins, Liver, Angiopoietin-Like Protein 3. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (N.T., V.M.L.).
- Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (V.M.L.).
- University of Tübingen, Germany (V.M.L.).
ORCID-Profile: Nayere Taebnia, Volker M Lauschke
Zitieren
APA
Taebnia, N., & Lauschke, V. M. (2024). Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(5), 1098-1100. https://doi.org/10.1161/atvbaha.124.320817
Vancouver
Taebnia N, Lauschke VM. Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(5):1098-1100. doi:10.1161/atvbaha.124.320817
BibTeX
@article{Taebnia2024,
author = {Taebnia, Nayere and Lauschke, Volker M},
title = {Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
volume = {44},
number = {5},
pages = {1098--1100},
doi = {10.1161/atvbaha.124.320817}
}
EUVIMED